Opinion
Video
Author(s):
Panelists discuss how vitiligo treatment delays, psychosocial effects, and emerging therapies impact standard of care for patients through case-based analysis.
Advances in Vitiligo Treatment Focus on Immunomodulatory Pathways, Cellular Grafting, and Emerging Drug Targets
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Monobenzone May Heighten Oxidative Stress and Systemic Health Concerns, Study Suggests
ReV Up Your Vitiligo Treatment Strategies
Exploring Afamelanotide for Vitiligo: Insights into the CUV 105 Phase 3 Clinical Trial
Oral Silymarin Plus Hair Follicle Transplantation Efficacious in Refractory Vitiligo